Lobbying activity

Q2

FARRAGUT PARTNERS LLP for GENENTECH

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues

View → Q2

INFUSION PROVIDERS ALLIANCE for INFUSION PROVIDERS ALLIANCE

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues

View → Q2

CARDINAL HEALTH, INC. for CARDINAL HEALTH INC

2nd Quarter (Apr 1 - June 30) 2026 · Ohio · House · Senate

Health Issues, Manufacturing, Trade (domestic/foreign), Tariff (miscellaneous tariff bills)

View → Q2

TIBER CREEK GROUP for TAKEDA PHARMACEUTICALS AMERICA, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid

View → Q2

TIBER CREEK GROUP for MERCK & CO., INC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Trade (domestic/foreign), Health Issues

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $50,000.00 income

Pharmacy

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income

Pharmacy

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income

Pharmacy

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income

Pharmacy

View → Q2

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q2

TIBER CREEK GROUP for DAIICHI SANKYO, INC.

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View → Q2

NORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER

2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing

View → Q2

COMMUNITY ONCOLOGY ALLIANCE for COMMUNITY ONCOLOGY ALLIANCE

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Medicare/Medicaid

View → 2A

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid

View → Q2

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Budget/Appropriations

View → Q2

ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations

View → RR

FARRAGUT PARTNERS LLP for TAKEDA PHARMACEUTICALS AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia

Health Issues

View → RR

FARRAGUT PARTNERS LLP for SIEMENS HEALTHINEERS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia

Health Issues

View → Q1

AMERICAN COLLEGE OF RHEUMATOLOGY for AMERICAN COLLEGE OF RHEUMATOLOGY

1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate

Health Issues, Budget/Appropriations, Medicare/Medicaid

View → Q1

CENCORA, INC. for CENCORA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Medicare/Medicaid, Pharmacy, Health Issues, Taxation/Internal Revenue Code

View → Q1

NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing

View → Q1

AVENUE SOLUTIONS for LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA)

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

AVENUE SOLUTIONS for GENENTECH USA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing

View → Q1

TIBER CREEK GROUP for DAIICHI SANKYO, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View →